美国药典规定的无菌检查方法
Alternative Thioglycollate Medium
Prepare a mixture having the same composition as that of the Fluid
Thioglycollate Medium, but omitting the agar and the resazurin sodium
solution, sterilize as directed above, and allow to cool prior to use. The pH
after sterilization is 7.1 ± 0.2. Incubate under anaerobic conditions for the
duration of the incubation period.
Alternative Fluid Thioglycollate Medium is to be incubated at 32.5 ± 2.5.
Soybean–Casein Digest Medium(TSB)
Pancreatic Digest of Casein 17.0 g
Papaic Digest of Soybean Meal 3.0 g
Sodium Chloride 5.0 g
Dibasic Potassium Phosphate 2.5 g
Dextrose (C6H12O6·H2O) 2.5/2.3 g
Purified Water 1000 mL
Dissolve the solids in the Purified Water, heating slightly to effect a
solution. Cool the solution to room temperature, and adjust the pH with 1 N
sodium hydroxide so that, after sterilization, it will have a pH of 7.3 ±
0.2. Filter, if necessary to clarify, dispense into suitable containers, and
sterilize using a validated procedure. Store at a temperature between 2 and 25
in a sterile well-closed container, unless it is intended for immediate use.
Soybean–Casein Digest Medium is to be incubated at 22.5 ± 2.5.
Media for Penicillins or Cephalosporins
Where sterility test media are to be used in the Direct Inoculation of
the Culture Medium method under Test for Sterility of the Product to be
Examined, modify the preparation of Fluid Thioglycollate Medium and the
Soybean–Casein Digest Medium as follows. To the containers of each medium,
transfer aseptically a quantity of b-lactamase sufficient to inactivate the
amount of antibiotic in the specimen under test. Determine the quantity of b-
lactamase required to inactivate the antibiotic by using a b-lactamase
preparation that has been assayed previously for its penicillin- or
cephalosporin-inactivating power. [NOTE—Supplemented b-lactamase media can
also be used in the membrane filtration test.]
Alternatively (in an area completely separate from that used for sterility
testing), confirm that an appropriate amount of b-lactamase is incorporated
into the medium, following either method under Validation Test, using less
than 100 colony-forming units (cfu) of Staphylococcus aureus (see Table 1) as
the challenge. Typical microbial growth of the inoculated culture must be
observed as a confirmation that the b-lactamase concentration is appropriate.
Table 1. Strains of the Test Microorganisms Suitable for Use in the Growth
美国药典USP31 71 无菌检查法 双语版_医药卫生_专业资料。usp 无菌检测美国药典 USP31-NF26 无菌检查法《71》.doc 71 STERILITY TESTS 无菌检查法 Portions ...
无菌USP71中文版_中医中药_医药卫生_专业资料。美国药典 USP31 <71> 无菌检查法无菌检查法此通则的各部分已经与欧洲药典和/或日本药典的对应部分做了协调。不一...
美国药典(usp28、nf23)附录无菌检查_专业资料。无菌检查7 0中国药品标准 20 年第 706 卷第 6期 (40总7) TuSadrsCi20,o. o6hg nadoha 6v17 . tf n0N 国...
无菌检验——隔离器系统验证 USP <1208>Sterility Testing—Validation of Isolator System/General informance 这部分是用于无菌检验隔离器系统的简明验证指南(注意:在...
USP对无菌检验隔离器验证的技术要求_专业资料。新版GMP新理念及无菌药品相关技术可以分享。药厂与GMP 2010年 第31卷 第2期 4月20日出版 Pharmaceutical & Engineer...
微生物检测方法-USP_生物学_自然科学_专业资料。美国药典微生物检测部分翻译<61>非无菌产品微生物检查:微生物计数检查简介: 下述方法能够对在有氧条件下生长的嗜温...
规范药品质量检查方法的管理,确保药品所用无菌检验方法的可行性、检验 结果的可靠...《中华人民共和国药典 2005 年版》增补版附录ⅪH 无菌检查法 《USP--31》 ...
2005年版 药典无菌检查法中将抑细菌和抑真菌试 验改变为方法验证试验。 ? 2005年版无菌检查法主要方面与USP、BP的比较 比较项目 ChP2005 USP29 BP2002 检验...
16页 免费 USP无菌检验-隔离器系统... 11页 免费喜欢此文档的还喜欢 USP-31...分析方法验证指南 1、目的 本文件的目的是为分析方法验证的数据收集提供基本指南...
热门文档